Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Overexpression of cyclin-dependent kinase 4 protein in extramammary Paget's disease.

Urata K, Kajihara I, Myangat TM, Tasaki Y, Otsuka-Maeda S, Sawamura S, Kanazawa-Yamada S, Sakamoto R, Makino K, Aoi J, Igata T, Makino T, Masuguchi S, Fukushima S, Jinnin M, Ihn H.

J Dermatol. 2019 May;46(5):444-448. doi: 10.1111/1346-8138.14858. Epub 2019 Mar 21.

PMID:
30897229
2.

Multiple Skin Abscesses Caused by Rhizopus sp. Infection after Candida albicans Infection in an Immunocompromised Patient.

Makino K, Aoi J, Egashira S, Honda N, Kubo Y, Kawakami Y, Hayashi H, Mochizuki T.

Med Mycol J. 2019;60(1):17-21. doi: 10.3314/mmj.18-00002.

3.

Serum cell-free DNA levels are a useful marker for extramammary Paget disease.

Mijiddorj T, Kajihara I, Tasaki Y, Otsuka-Maeda S, Sakamoto R, Sawamura S, Kanazawa-Yamada S, Egashira S, Inoue K, Makino K, Miyashita A, Aoi J, Igata T, Makino T, Masuguchi S, Fukushima S, Jinnin M, Morinaga J, Ikeda T, Ihn H.

Br J Dermatol. 2019 Sep;181(3):505-511. doi: 10.1111/bjd.17709. Epub 2019 Apr 7.

PMID:
30706452
4.

Recurrent Fusion Gene ADCK4-NUMBL in Cutaneous Squamous Cell Carcinoma Mediates Cell Proliferation.

Egashira S, Jinnin M, Makino K, Ajino M, Shimozono N, Okamoto S, Tazaki Y, Hirano A, Ide M, Kajihara I, Aoi J, Harada M, Igata T, Masuguchi S, Fukushima S, Ihn H.

J Invest Dermatol. 2019 Apr;139(4):954-957. doi: 10.1016/j.jid.2018.09.030. Epub 2018 Nov 2. No abstract available.

PMID:
30395845
5.

Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma.

Kubo Y, Fukushima S, Inamori Y, Tsuruta M, Egashira S, Yamada-Kanazawa S, Nakahara S, Tokuzumi A, Miyashita A, Aoi J, Kajihara I, Tomita Y, Wakamatsu K, Jinnin M, Ihn H.

J Dermatol Sci. 2019 Jan;93(1):33-40. doi: 10.1016/j.jdermsci.2018.10.001. Epub 2018 Oct 6.

PMID:
30318169
6.

Serum cytokine profiles are altered in patients with progressive infantile hemangioma.

Yamashita T, Jinnin M, Makino K, Kajihara I, Aoi J, Masuguchi S, Fukushima S, Ihn H.

Biosci Trends. 2018 Sep 19;12(4):438-441. doi: 10.5582/bst.2018.01118. Epub 2018 Aug 26.

7.

Simple and effective modification of the axial frontonasal flap to prevent flap distortion.

Aoi J, Kajihara I, Masuguchi S, Fukushima S, Ihn H.

J Dermatol. 2019 Jan;46(1):e46-e47. doi: 10.1111/1346-8138.14506. Epub 2018 Jun 15. No abstract available.

PMID:
29905387
8.

Enhanced Recovery After Surgery program with dexamethasone administration for major head and neck surgery with free tissue transfer reconstruction: initial institutional experience.

Imai T, Kurosawa K, Yamaguchi K, Satake N, Asada Y, Matsumoto K, Morita S, Saijo S, Aoi J, Fujii K, Kishimoto K, Goto T, Matsuura K.

Acta Otolaryngol. 2018 Jul;138(7):664-669. doi: 10.1080/00016489.2018.1429651. Epub 2018 Jan 31.

PMID:
29385889
9.

Do scleroderma patients look young?: Evaluation by using facial imaging system.

Sawamura S, Jinnin M, Kajihara I, Makino K, Aoi J, Ichihara A, Makino T, Fukushima S, Ihn H.

Drug Discov Ther. 2017;11(6):342-345. doi: 10.5582/ddt.2017.01059.

10.

Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma.

Egashira S, Jinnin M, Ajino M, Shimozono N, Okamoto S, Tasaki Y, Hirano A, Ide M, Kajihara I, Aoi J, Harada M, Igata T, Masuguchi S, Fukushima S, Ihn H.

Sci Rep. 2017 Oct 4;7(1):12654. doi: 10.1038/s41598-017-12836-z.

11.

Intratumor dihydropyrimidine dehydrogenase mRNA expression levels are decreased in extramammary Paget's disease.

Nakamura Y, Kajihara I, Yamada-Kanazawa S, Maeda-Otsuka S, Johno T, Aoi J, Igata T, Masuguchi S, Fukushima S, Jinnin M, Ihn H.

Drug Discov Ther. 2017 Jul 31;11(3):152-155. doi: 10.5582/ddt.2017.01022. Epub 2017 Jul 11.

12.

Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis.

Tanigawa H, Miyata K, Tian Z, Aoi J, Kadomatsu T, Fukushima S, Ogata A, Takeda N, Zhao J, Zhu S, Terada K, Endo M, Morinaga J, Sugizaki T, Sato M, Morioka MS, Manabe I, Mashimo Y, Hata A, Taketomi Y, Yamamoto K, Murakami M, Araki K, Jinnin M, Ihn H, Oike Y.

Sci Rep. 2016 Oct 4;6:34690. doi: 10.1038/srep34690.

13.

Myasthenic crisis and polymyositis induced by one dose of nivolumab.

Kimura T, Fukushima S, Miyashita A, Aoi J, Jinnin M, Kosaka T, Ando Y, Matsukawa M, Inoue H, Kiyotani K, Park JH, Nakamura Y, Ihn H.

Cancer Sci. 2016 Jul;107(7):1055-8. doi: 10.1111/cas.12961.

14.

Cytokine expression profiles in the sera of cutaneous squamous cell carcinoma patients.

Yamada S, Jinnin M, Kajihara I, Nakashima T, Aoi J, Harada M, Igata T, Masuguchi S, Fukushima S, Ihn H.

Drug Discov Ther. 2016;10(3):172-6. doi: 10.5582/ddt.2016.01032. Epub 2016 May 7.

15.

Immunotherapy against Metastatic Melanoma with Human iPS Cell-Derived Myeloid Cell Lines Producing Type I Interferons.

Miyashita A, Fukushima S, Nakahara S, Kubo Y, Tokuzumi A, Yamashita J, Aoi J, Haruta M, Senju S, Nishimura Y, Jinnin M, Ihn H.

Cancer Immunol Res. 2016 Mar;4(3):248-58. doi: 10.1158/2326-6066.CIR-15-0096. Epub 2015 Dec 29.

16.

Investigation of FOXM1 as a Potential New Target for Melanoma.

Miyashita A, Fukushima S, Nakahara S, Yamashita J, Tokuzumi A, Aoi J, Ichihara A, Kanemaru H, Jinnin M, Ihn H.

PLoS One. 2015 Dec 7;10(12):e0144241. doi: 10.1371/journal.pone.0144241. eCollection 2015.

17.

Enhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment.

Koga A, Kajihara I, Yamada S, Makino K, Ichihara A, Aoi J, Makino T, Fukushima S, Jinnin M, Ihn H.

J Dermatol. 2016 May;43(5):522-5. doi: 10.1111/1346-8138.13178. Epub 2015 Oct 28.

PMID:
26507968
18.

Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma.

Ichigozaki Y, Fukushima S, Jinnin M, Miyashita A, Nakahara S, Tokuzumi A, Yamashita J, Kajihara I, Aoi J, Masuguchi S, Zhongzhi W, Ihn H.

Exp Dermatol. 2016 Jan;25(1):67-9. doi: 10.1111/exd.12868. Epub 2015 Nov 23. No abstract available.

PMID:
26440365
19.

Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel.

Kajihara I, Kanemaru H, Miyake T, Aoi J, Masuguchi S, Fukushima S, Jinnin M, Ihn H.

Drug Discov Ther. 2015 Feb;9(1):75-7. doi: 10.5582/ddt.2015.01005.

20.

Hair shaft miRNA-221 levels as a new tumor marker of malignant melanoma.

Inada T, Fukushima S, Murai M, Jinnin M, Miyashita A, Nakahara S, Yamashita J, Aoi J, Masuguchi S, Ihn H.

J Dermatol. 2015 Feb;42(2):198-201. doi: 10.1111/1346-8138.12730. Epub 2014 Dec 10.

PMID:
25492219
21.

Aesthetic reconstruction of defects in the lateral side wall of the nose using a local V-Y flap.

Aoi J, Masuguchi S, Fukushima S, Jinnin M, Ihn H.

J Dermatol. 2014 Nov;41(11):1026-8. doi: 10.1111/1346-8138.12660. No abstract available.

PMID:
25346309
22.

A simple and effective reconstructive technique for repairing defects of the upper lip using a hatchet flap.

Aoi J, Nagamoto E, Masuguchi S, Fukushima S, Jinnin M, Ihn H.

J Dermatol. 2014 Nov;41(11):1025-6. doi: 10.1111/1346-8138.12645. No abstract available.

PMID:
25346308
23.

A case of anaplastic large cell lymphoma of skeletal muscle.

Kubo Y, Aoi J, Johno T, Makino T, Sakai K, Masuguchi S, Fukushima S, Jinnin M, Inoue Y, Ihn H.

J Dermatol. 2014 Nov;41(11):999-1002. doi: 10.1111/1346-8138.12641. Epub 2014 Oct 8.

PMID:
25292453
24.

The expression profile of the toll-like receptor family in scleroderma dermal fibroblasts.

Sakoguchi A, Nakayama W, Jinnin M, Wang Z, Yamane K, Aoi J, Makino K, Kajihara I, Ichihara A, Makino T, Fukushima S, Sakai K, Inoue Y, Ihn H.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-4-9. Epub 2014 Jun 6.

PMID:
24959869
25.

Evaluation of sentinel node biopsy for cutaneous squamous cell carcinoma.

Fukushima S, Masuguchi S, Igata T, Harada M, Aoi J, Miyashita A, Nakahara S, Inoue Y, Jinnin M, Shiraishi S, Yamashita Y, Ishihara T, Ihn H.

J Dermatol. 2014 Jun;41(6):539-41. doi: 10.1111/1346-8138.12508.

PMID:
24909214
26.

Knockout of endothelial cell-derived endothelin-1 attenuates skin fibrosis but accelerates cutaneous wound healing.

Makino K, Jinnin M, Aoi J, Kajihara I, Makino T, Fukushima S, Sakai K, Nakayama K, Emoto N, Yanagisawa M, Ihn H.

PLoS One. 2014 May 22;9(5):e97972. doi: 10.1371/journal.pone.0097972. eCollection 2014.

27.

Increased CCL22 expression in psoriatic skin predicts a good response to infliximab therapy.

Kusumoto S, Kajihara I, Nagamoto E, Makino K, Ichihara A, Aoi J, Johno T, Makino T, Fukushima S, Jinnin M, Ihn H.

Br J Dermatol. 2014 Nov;171(5):1259-61. doi: 10.1111/bjd.13091. Epub 2014 Oct 22. No abstract available.

PMID:
24804833
28.

The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin α5β1, p38 MAPK, and matrix metalloproteinases.

Odagiri H, Kadomatsu T, Endo M, Masuda T, Morioka MS, Fukuhara S, Miyamoto T, Kobayashi E, Miyata K, Aoi J, Horiguchi H, Nishimura N, Terada K, Yakushiji T, Manabe I, Mochizuki N, Mizuta H, Oike Y.

Sci Signal. 2014 Jan 21;7(309):ra7. doi: 10.1126/scisignal.2004612.

PMID:
24448647
29.

Serum levels of leptin receptor in patients with malignant melanoma as a new tumor marker.

Mizutani H, Fukushima S, Masuguchi S, Yamashita J, Miyashita A, Nakahara S, Aoi J, Inoue Y, Jinnin M, Ihn H.

Exp Dermatol. 2013 Nov;22(11):748-9. doi: 10.1111/exd.12238.

PMID:
24433182
30.

Phase II study of i.v. interferon-gamma in Japanese patients with mycosis fungoides.

Sugaya M, Tokura Y, Hamada T, Tsuboi R, Moroi Y, Nakahara T, Amano M, Ishida S, Watanabe D, Tani M, Ihn H, Aoi J, Iwatsuki K.

J Dermatol. 2014 Jan;41(1):50-6. doi: 10.1111/1346-8138.12341. Epub 2013 Dec 20.

PMID:
24354781
31.

The proportion of lymphocytic inflammation with CD123-positive cells in lupus erythematous profundus predict a clinical response to treatment.

Miyashita A, Fukushima S, Makino T, Yoshino Y, Yamashita J, Honda N, Aoi J, Ichihara A, Jinnin M, Inoue Y, Ihn H.

Acta Derm Venereol. 2014 Sep;94(5):563-7. doi: 10.2340/00015555-1777.

32.

Angiopoietin-like protein 2 accelerates carcinogenesis by activating chronic inflammation and oxidative stress.

Aoi J, Endo M, Kadomatsu T, Miyata K, Ogata A, Horiguchi H, Odagiri H, Masuda T, Fukushima S, Jinnin M, Hirakawa S, Sawa T, Akaike T, Ihn H, Oike Y.

Mol Cancer Res. 2014 Feb;12(2):239-49. doi: 10.1158/1541-7786.MCR-13-0336. Epub 2013 Nov 20.

33.

Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.

Shiiyama R, Fukushima S, Jinnin M, Yamashita J, Miyashita A, Nakahara S, Kogi A, Aoi J, Masuguchi S, Inoue Y, Ihn H.

Melanoma Res. 2013 Oct;23(5):366-72. doi: 10.1097/CMR.0b013e328363e485.

PMID:
23863473
34.

Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.

Aoi J, Makino K, Sakai K, Masuguchi S, Fukushima S, Jinnin M, Inoue Y, Koga H, Hashimoto T, Ihn H.

J Dermatol. 2013 Apr;40(4):285-6. doi: 10.1111/1346-8138.12095. Epub 2013 Feb 11. No abstract available.

PMID:
23398274
35.

Serum epidermal growth factor receptor levels in patients with malignant melanoma.

Kanemura H, Fukushima S, Yamashita J, Jinnin M, Sakai K, Masuguchi S, Aoi J, Makino T, Inoue Y, Ihn H.

Clin Exp Dermatol. 2013 Mar;38(2):172-7. doi: 10.1111/ced.12022.

PMID:
23397945
36.

The rs2910164 G>C polymorphism in microRNA-146a is associated with the incidence of malignant melanoma.

Yamashita J, Iwakiri T, Fukushima S, Jinnin M, Miyashita A, Hamasaki T, Makino T, Aoi J, Masuguchi S, Inoue Y, Ihn H.

Melanoma Res. 2013 Feb;23(1):13-20. doi: 10.1097/CMR.0b013e32835c5b30.

PMID:
23222547
37.

Case of blastic plasmacytoid dendritic cell neoplasm.

Aoi J, Ogata A, Makino T, Sakai K, Masuguchi S, Fukushima S, Jinnin M, Inoue Y, Ihn H.

J Dermatol. 2012 Dec;39(12):1066-7. doi: 10.1111/j.1346-8138.2012.01656.x. Epub 2012 Sep 13. No abstract available.

PMID:
22970734
38.

microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma.

Etoh M, Jinnin M, Makino K, Yamane K, Nakayama W, Aoi J, Honda N, Kajihara I, Makino T, Fukushima S, Ihn H.

Arch Dermatol Res. 2013 Jan;305(1):9-15. doi: 10.1007/s00403-012-1287-4. Epub 2012 Sep 11.

PMID:
22965811
39.

Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts.

Makino K, Jinnin M, Aoi J, Hirano A, Kajihara I, Makino T, Sakai K, Fukushima S, Inoue Y, Ihn H.

J Invest Dermatol. 2013 Jan;133(1):110-9. doi: 10.1038/jid.2012.252. Epub 2012 Jul 26.

40.

Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.

Yamane K, Jinnin M, Etoh T, Kobayashi Y, Shimozono N, Fukushima S, Masuguchi S, Maruo K, Inoue Y, Ishihara T, Aoi J, Oike Y, Ihn H.

J Mol Med (Berl). 2013 Jan;91(1):69-81. doi: 10.1007/s00109-012-0935-7. Epub 2012 Jul 25.

PMID:
22828925
41.

Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis.

Endo M, Nakano M, Kadomatsu T, Fukuhara S, Kuroda H, Mikami S, Hato T, Aoi J, Horiguchi H, Miyata K, Odagiri H, Masuda T, Harada M, Horio H, Hishima T, Nomori H, Ito T, Yamamoto Y, Minami T, Okada S, Takahashi T, Mochizuki N, Iwase H, Oike Y.

Cancer Res. 2012 Apr 1;72(7):1784-94. doi: 10.1158/0008-5472.CAN-11-3878. Epub 2012 Feb 16.

42.

The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis.

Ogata A, Endo M, Aoi J, Takahashi O, Kadomatsu T, Miyata K, Tian Z, Jinnin M, Fukushima S, Ihn H, Oike Y.

Biochem Biophys Res Commun. 2012 Feb 17;418(3):494-9. doi: 10.1016/j.bbrc.2012.01.052. Epub 2012 Jan 18.

PMID:
22281496
43.

Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis.

Aoi J, Endo M, Kadomatsu T, Miyata K, Nakano M, Horiguchi H, Ogata A, Odagiri H, Yano M, Araki K, Jinnin M, Ito T, Hirakawa S, Ihn H, Oike Y.

Cancer Res. 2011 Dec 15;71(24):7502-12. doi: 10.1158/0008-5472.CAN-11-1758. Epub 2011 Oct 31.

44.

Nifedipine increases energy expenditure by increasing PGC-1α expression in skeletal muscle.

Tian Z, Miyata K, Tabata M, Yano M, Tazume H, Aoi J, Takahashi O, Araki K, Kawasuji M, Oike Y.

Hypertens Res. 2011 Nov;34(11):1221-7. doi: 10.1038/hr.2011.129. Epub 2011 Aug 4.

PMID:
21814214
45.

Protective effect of (+)-catechin against 5-fluorouracil-induced myelosuppression in mice.

Takano F, Tanaka T, Aoi J, Yahagi N, Fushiya S.

Toxicology. 2004 Sep 1;201(1-3):133-42.

PMID:
15297028

Supplemental Content

Support Center